供精可提高高龄女性ICSI活产率
该回顾性多中心队列研究纳入2015-2019年间755个ICSI新鲜胚胎移植周期,比较供精与配偶精在非高龄(<37岁)和高龄(≥37岁)患者中的结局。多因素分析显示供精仅在高龄患者中与活产正相关(P=0.02),供精组活产率和分娩率更高、流产率更低。
要点
- 高龄(≥37岁)ICSI周期中,供精与活产正相关(P=0.02)。
- 高龄供精组活产率25.4% vs 配偶精14.5%,分娩率22.5% vs 13.5%。
- 高龄供精组流产率18.0% vs 配偶精39.5%,降低一半以上。
核心结论
- 供精可提高高龄(≥37岁)患者ICSI活产率并降低流产率。
研究设计与样本
- 回顾性多中心队列研究,纳入2015-2019年755个ICSI新鲜胚胎移植周期。
- 其中337个为首次配偶精周期(正常精液+自体卵母细胞),418个为首次供精周期(供精+自体卵母细胞)。
- 患者为24-42岁白人,来自三家生殖中心。
主要发现
- 多因素分析显示供精仅在高龄(≥37岁,n=477)中与活产正相关(P=0.02),非高龄(<37岁,n=278)中无此关联。
- 高龄供精组活产率25.4% vs 配偶精组14.5%,分娩率22.5% vs 13.5%(P<0.01)。
- 高龄供精组流产率18.0% vs 配偶精组39.5%(P<0.01)。
关键数值与推荐
- 多因素模型纳入MII卵母细胞数、移植胚胎数和母亲年龄。
- 高龄供精组活产率和分娩率较配偶精组高70-75%。
临床怎么用
- 对高龄(≥37岁)ICSI患者,供精可能是改善活产结局的有效策略。
局限性
- 回顾性研究,供精组与配偶精对照组患者特征存在差异。
- 各生殖中心供精周期比例不同,虽经统计控制但仍可能影响结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can sperm donation increase live birth rates following ICSI in advanced maternal age (AMA) patients? SUMMARY ANSWER: Sperm donation increases the live birth rate in AMA ICSI cycles. WHAT IS KNOWN ALREADY: In ICSI practice, sperm donation has been predominantly applied to overcome male infertility. The involvement of paternal age and lower sperm quality in the severe reduction in fertility observed in AMA patients remains to be clarified. STUDY DESIGN, SIZE, DURATION: Retrospective multicenter cohort study including data generated between 2015 and 2019 from 755 ICSI cycles achieving a fresh embryo transfer, of which 337 were first homologous cycles (normozoospermic partner sperm and homologous oocytes) and 418 were first sperm donation cycles (donor sperm and homologous oocytes). The association of sperm origin (partner vs donor) with live birth was assessed by multivariate analysis in non-AMA (<37 years, n = 278) and AMA (≥37 years, n = 477) patients, separately, including in the model all variables previously found to be associated with live birth in a univariate analysis (number of MII oocytes recovered, number of embryos transferred, and maternal age). ICSI outcomes were compared between sperm donation and homologous cycles in overall, non-AMA and AMA patients. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study was conducted in three fertility clinics and included 755 Caucasian patients aged 24-42 years undergoing their first homologous or sperm donation ICSI cycle achieving a fresh embryo transfer. MAIN RESULTS AND THE ROLE OF CHANCE: The multivariate analysis revealed that sperm donation was positively associated with the likelihood of a live birth independently of all other variables tested in AMA (P = 0.02), but not in non-AMA patients. Live birth, delivery, and miscarriage rates differed substantially between sperm donation and homologous AMA cycles; live birth and delivery rates were 70-75% higher (25.4% vs 14.5% and 22.5% vs 13.5%, respectively; P < 0.01), while miscarriage occurrence was less than half (18.0% vs 39.5%; P < 0.01) in sperm donation compared to homologous AMA cycles. LIMITATIONS, REASONS FOR CAUTION: This study is limited by its retrospective nature, differences in patients profiles between sperm donation and homologous-control groups and varying proportion of donor cycles between fertility centers, although these variations have been controlled for in the statistical analysis. WIDER IMPLICATIONS OF THE FINDINGS: The findings suggest that sperm donation increases live birth rates while reducing miscarriage occurrence in AMA patients, and thus may be a valid strategy to improve ICSI outcomes in this growing and challenging patient group. STUDY FUNDING/COMPETING INTEREST(S): N/A. TRIAL REGISTRATION NUMBER: N/A.
引用
- Mignini Renzini M, Dal Canto M, Guglielmo MC, et al. Sperm donation: an alternative to improve post-ICSI live birth rates in advanced maternal age patients. Hum Reprod. 2021. PMID: 34143887. doi:10.1093/humrep/deab148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。